| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K24690302 |
| PharmacoGx | BRD-K24690302 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABHD15 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | PRSS46 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | BARD1 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | WIPF3 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | G3BP2 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | EFNA5 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | FUT3 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | EXOC3L1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | SEMA4B | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | NCK2 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
